• About us
    • About us
    • Executive management
    • Advisory board
    • Scientific board
    • Investors
    • Partners
  • Products
    • MailPan®
    • ExOlin®
  • Indications
    • Diabetes
    • Hemophilia
    • Obesity
  • Innovation
    • iNanoBIT
    • Encapsulin
    • deLIVER
  • Media & Rewards
  • News
  • Contact
  • EN
    • FR
Defymed Logo
  • About us
    • About us
    • Executive management
    • Advisory board
    • Scientific board
    • Investors
    • Partners
  • Products
    • MailPan®
    • ExOlin®
  • Indications
    • Diabetes
    • Hemophilia
    • Obesity
  • Innovation
    • iNanoBIT
    • Encapsulin
    • deLIVER
  • Media & Rewards
  • News
  • Contact
  • EN
    • FR
  • Defymed is now on Facebook

    Home News Defymed is now on Facebook

Please follow our new page and do not hesitate to share with your contacts in your social media:

==> https://facebook.com/Defymed/ <==

  • Recent posts

    • Defymed at the IPITA conference
    • Defymed at the Cell and Gene meeting on the MESA 2021
    • Defymed at the conference of the European Society for Biomaterials
Defymed Logo

Offices

  • 9 rue Calmette
    67200 Strasbourg
    France
  • + 33 (0)3 90 41 04 46

Laboratories

  • Centre Européen Étude du Diabète C.E.E.D.
    Boulevard René Leriche
    67200 Strasbourg
    France
  • + 33 (0)3 90 41 04 46
Contact us

Follow us :

All rights reserved Defymed 2022.

Privacy policy Legal notices Cookies
Defymed Adeliom Adeliom Agency